XTSE
AND
Market cap1.52bUSD
Nov 04, Last price
54.97CAD
Name
Andlauer Healthcare Group Inc
Chart & performance
P/E
33.37
P/S
3.31
EPS
1.65
Div yield, %
0.56%
Shrs. gr., 5y
1.60%
Rev. gr., 5y
17.54%
Revenues
650m
+0.39%
Net income
64m
-2.53%
CFO
124m
+19.14%
Dividend
Sep 29, 20250.12 CAD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Andlauer Healthcare Group Inc., established in 1991 and based in Vaughan, Canada, is a specialized supply chain and logistics provider catering exclusively to the healthcare sector throughout Canada and the United States. Operating as a subsidiary of Andlauer Management Group Inc., the company offers customized third-party logistics (3PL) and specialized transportation solutions, structured across its Specialized Transportation and Healthcare Logistics segments. Its comprehensive services encompass logistics and distribution, including client integration, inventory control, warehousing, and fulfillment, as well as packaging services like co-packing, re-packing, assembly, and custom work. Additionally, AHG provides crucial temperature-controlled transportation, air freight forwarding, and various ground delivery options, such as dedicated, last-mile, and courier services. Leveraging technology-enabled supply chain solutions, Andlauer Healthcare Group serves a wide range of clients—from healthcare manufacturers and wholesalers to distributors and other 3PL providers—handling an extensive array of products, including pharmaceuticals, vaccines, biologics, narcotics, medical devices, cosmetics, and consumer health items.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||